CNO Financial Group, Inc.·4

Apr 2, 4:06 PM ET

Williams Jeremy David 4

4 · CNO Financial Group, Inc. · Filed Apr 2, 2025

Insider Transaction Report

Form 4
Period: 2025-03-31
Williams Jeremy D.
Chief Actuary
Transactions
  • Sale

    Common Stock

    2025-03-31$41.51/sh11,300$469,06365,299 total
  • Sale

    Common Stock

    2025-04-02$41.77/sh3,393$141,72156,599 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2025-03-3111,3000 total
    Exercise: $17.38Exp: 2026-02-23Common Stock (11,300 underlying)
  • Exercise/Conversion

    Common Stock

    2025-03-31$17.38/sh+11,300$196,39476,599 total
  • Sale

    Common Stock

    2025-04-01$41.39/sh2,917$120,74959,992 total
  • Sale

    Common Stock

    2025-04-01$41.41/sh2,390$98,96562,909 total
Footnotes (5)
  • [F1]Shares sold pursuant to a Rule 10b5-1 trading plan adopted on November 20, 2024.
  • [F2]Reflects the weighted average sale price. Shares were sold at prices ranging from $41.03 per share to $41.73 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
  • [F3]Reflects the weighted average sale price. Shares were sold at prices ranging from $41.20 per share to $41.63 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
  • [F4]Reflects the weighted average sale price. Shares were sold at prices ranging from $41.36 per share to $41.97 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
  • [F5]One-half of the stock options vested on February 23, 2018, and one-half vested on February 23, 2019.

Documents

1 file
  • 4
    wk-form4_1743624385.xmlPrimary

    FORM 4